Recently, the role of toll-like receptor 4 (TLR4) signaling, which recognizes lipopolysaccharide on gram-negative bacteria, has been highlighted not only in the pathogenesis of NEC, but also in intestinal inflammation and inflammatory bowel disease [21]. This evidence concerns the gene TLR4 and inflammatory bowel disease.